Загрузка...
Potential Adiponectin Receptor Response Modifier Therapeutics
Many human diseases may benefit from adiponectin replacement therapy, but due to pharmacological disadvantages of the intact protein, druggable options focus on peptidic, and small molecule agonists of the adiponectin receptor. Peptide-based adiponectin replacement drug leads are derived from, or re...
Сохранить в:
| Опубликовано в: : | Front Endocrinol (Lausanne) |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6700268/ https://ncbi.nlm.nih.gov/pubmed/31456747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00539 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|